LEADER 01114nam a2200265 i 4500 001 991000667499707536 008 041130s2001 it 000 0 ita d 020 $a8817120723 035 $ab13255058-39ule_inst 040 $aDip.to Studi Giuridici$bita 100 1 $aSallustius Crispus, Gaius$0154956 245 13$aLa congiura di Catilina /$cGaio Crispo Sallustio ; prefazione, traduzione e note a cura di Lidia Storoni Mazzolani 250 $a17. ed 260 $aMilano :$bBiblioteca universale Rizzoli,$c2001 300 $a210 p. ;$c18 cm 440 0$aBUR Classici greci e latini ;$vL 72 500 $aTesto latino a fronte 700 1 $aStoroni Mazzolani, Lidia 907 $a.b13255058$b23-02-12$c30-11-04 912 $a991000667499707536 945 $aLE007 BUR LAT Sallustius 01-2001$g1$i2007000190029$lle007$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i15309794$z05-08-11 945 $aLE027 R-XXVI/BOL Sallustius 1$g1$lle027$o-$pE8.78$q-$rl$s- $t0$u0$v0$w0$x0$y.i13952274$z30-11-04 996 $aCongiura di Catilina$9290743 997 $aUNISALENTO 998 $ale007$ale027$b30-11-04$cm$da $e-$fita$git $h3$i0 LEADER 01111nam a2200289 i 4500 001 991002061989707536 005 20020508185826.0 008 990324s1972 fr ||| | fre 035 $ab10953565-39ule_inst 035 $aPARLA153805$9ExL 040 $aDip.to Scienze dell'Antichità$bita 041 1 $afre$agrc$hgrc 100 0 $aAristophanes$0602827 245 12$aL'assemblés des femmes; Ploutos /$cAristophane ; texte établi par Victor Coulon et traduit par Hilaire Van Daele 250 $a4. tirage 260 $aParis :$bLes Belles Lettres,$c1972 300 $a147 p. (15-147 doppie) ;$c20 cm. 490 0 $aCollection des Universités de France.$aSérie grecque 546 $aTesto greco a fronte 700 1 $aDaele, Hilaire :$cvan 740 0 $aPloutos 907 $a.b10953565$b10-05-18$c28-06-02 912 $a991002061989707536 945 $aLE007 I Coll. 3 Aristhophanes 05$g1$i2015000034625$lle007$o-$pE0.00$q-$rn$so $t0$u0$v0$w0$x0$y.i11061492$z28-06-02 996 $aAssemblés des femmes; Ploutos$93369627 997 $aUNISALENTO 998 $ale007$b01-01-99$cm$da $e-$ffre$gfr $h2$i1 LEADER 02235oam 2200637 450 001 9910708691903321 005 20181004102539.0 035 $a(CKB)5470000002470306 035 $a(OCoLC)896877796 035 $a(EXLCZ)995470000002470306 100 $a20141125d2014 ua 0 101 0 $aeng 135 $aurbn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDistinguishing acts of war in cyberspace $eassessment criteria, policy considerations, and response implications /$fJeffrey L. Caton 210 1$aCarlisle, PA :$cStrategic Studies Institute and U.S. Army War College Press,$d2014. 215 $a1 online resource (x, 102 pages) 300 $a"October 2014." 300 $aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. 311 $a1-58487-643-3 320 $aIncludes bibliographical references (pages 76-96). 517 $aDistinguishing acts of war in cyberspace 606 $aComputer crimes$zUnited States 606 $aCyberspace$xSecurity measures$zUnited States 606 $aInformation warfare$zUnited States 606 $aCyberspace$xGovernment policy$zUnited States 606 $aCyberterrorism$zUnited States 606 $aComputer crimes$2fast 606 $aCyberspace$xGovernment policy$2fast 606 $aCyberterrorism$2fast 606 $aInformation warfare$2fast 607 $aUnited States$2fast 615 0$aComputer crimes 615 0$aCyberspace$xSecurity measures 615 0$aInformation warfare 615 0$aCyberspace$xGovernment policy 615 0$aCyberterrorism 615 7$aComputer crimes. 615 7$aCyberspace$xGovernment policy. 615 7$aCyberterrorism. 615 7$aInformation warfare. 700 $aCaton$b Jeffrey L.$01388965 712 02$aArmy War College (U.S.).$bStrategic Studies Institute, 712 02$aArmy War College (U.S.).$bPress, 801 0$bKSG 801 1$bKSG 801 2$bDID 801 2$bAAU 801 2$bOCLCF 801 2$bGPO 906 $aBOOK 912 $a9910708691903321 996 $aDistinguishing acts of war in cyberspace$93498867 997 $aUNINA LEADER 04068nam 22006015 450 001 9910373912603321 005 20251113181919.0 010 $a981-329-393-4 024 7 $a10.1007/978-981-32-9393-9 035 $a(CKB)4100000009938171 035 $a(MiAaPQ)EBC5983966 035 $a(DE-He213)978-981-32-9393-9 035 $a(PPN)260301213 035 $a(EXLCZ)994100000009938171 100 $a20191123d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aExploring Pancreatic Metabolism and Malignancy /$fedited by Ganji Purnachandra Nagaraju, Aramati BM Reddy 205 $a1st ed. 2019. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2019. 215 $a1 online resource (269 pages) 311 08$a981-329-392-6 327 $aChapter 1. Biology of pancreas and possible diseases -- Chapter 2. Pancreatitis: Clinical aspects of inflammatory phenotypes -- Chapter 3. Diabetes and Pancreatic Cancer ? A Bidirectional Relationship Perspective -- Chapter 4. Metabolic Adaptations in Diabetes Mellitus and Cancer -- Chapter 5. Role of Mitochondria in pancreatic metabolism, diabetes and cancer -- Chapter 6. Targeting Mitochondrial Enzymes in Pancreatic Cancer -- Chapter 7. Diabetes with Pancreatic ductal adenocarcinoma -- Chapter 8. Role of Inflammatory Cytokines in the initiation and progression of Pancreatic Cancer -- Chapter 9. Perspectives and molecular understanding of pancreatic cancer stem cells -- Chapter 10. The Role of Hypoxia Inducible Factor-1? in Pancreatic Cancer and Diabetes Mellitus -- Chapter 11. Role of Heat shock protein 90 in Diabetes and Pancreatic Cancer Management -- Chapter 12. Insulin resistance is a common core tethered to diabetes and pancreatic cancerrisk -- Chapter 13. Immunotherapy for Diabetogenic Pancreatitis and Pancreatic Cancer: An Update -- Chapter 14. Exosomes: Mediators and Therapeutic Targets of Diabetes and Pancreatic Cancer -- Chapter 15. Methods and models in exploring pancreatic functions. 330 $aThis book comprehensively describes the association between metabolic syndrome and pancreatic cancer progression, and the mechanism of action and target definition with a view to drug discovery. Metabolic syndrome, which includes adnominal obesity, hypertension, dyslipidemia, and hyperglycemia, has recently been shown to play an important role in the etiology and progression of various cancers. Further, obesity and diabetes have been associated with an increased incidence of gastric cancers. The book reviews the key biological mechanisms underlying the association between metabolic dysregulation, including obesity-associated enhancement of growth factor signaling, inflammation, and perturbation in pancreatic cancer cell growth and metastasis. It also illustrates the role of the inflammatory signaling pathway in metabolic diseases as well as tumor growth and explores the potential of these pathways as the rational targets for pancreatic cancer therapy. Lastly, the book offers a comprehensive description of the challenges associated with diabetes and pancreatic cancer therapy. 606 $aCancer 606 $aDiseases 606 $aHuman physiology 606 $aImmunology 606 $aCancer Biology 606 $aDiseases 606 $aHuman Physiology 606 $aImmunology 615 0$aCancer. 615 0$aDiseases. 615 0$aHuman physiology. 615 0$aImmunology. 615 14$aCancer Biology. 615 24$aDiseases. 615 24$aHuman Physiology. 615 24$aImmunology. 676 $a616.99437 702 $aNagaraju$b Ganji Purnachandra$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aBM Reddy$b Aramati$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910373912603321 996 $aExploring Pancreatic Metabolism and Malignancy$92020956 997 $aUNINA